Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Allopurinol Impact on HRQOL in Cirrhotic Patients
NCT05828836Phase 3Completed
- Sponsor
- Tanta University
- Start
- Jun 2022
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of allopurinol in Liver cirrhosis (LC), sponsored by Tanta University. Started Jun 2022; status: completed.
02
Drugs
allopurinol
03
Conditions
Liver cirrhosis (LC)
Beyond the preview
Go deeper on NCT05828836.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05828836.